<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Singh Y</submitter><funding>Florida Atlantic University</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>2974-2980</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8378340</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(16)</volume><pubmed_abstract>The amyloid-β precursor protein (APP) undergoes proteolytic cleavage by α-, β-, and γ-secretases, to determine its fate in Alzheimer's disease (AD) pathogenesis. Recent findings suggest a possible role of &lt;i>O&lt;/i>-glycosylation in APP's proteolytic processing. Therefore, we synthesized native and Swedish-double-mutated APP (glyco)peptides with Tyr&lt;sup>681&lt;/sup>-&lt;i>O&lt;/i>-GalNAc. We studied conformational changes and proteolytic processing using circular dichroism (CD) spectroscopy and enzyme cleavage assay, respectively. CD analysis was carried out in four solvent systems to evaluate peptide environment and &lt;i>O&lt;/i>-glycosylation induced conformational changes. The Swedish mutation and Tyr&lt;sup>681&lt;/sup>-&lt;i>O&lt;/i>-GalNAc were the key factors driving conformational changes. Furthermore, the le</pubmed_abstract><journal>ACS chemical neuroscience</journal><pubmed_title>Tyrosine &lt;i>O&lt;/i>-GalNAc Alters the Conformation and Proteolytic Susceptibility of APP Model Glycopeptides.</pubmed_title><pmcid>PMC8378340</pmcid><funding_grant_id>R15 CA249788</funding_grant_id><funding_grant_id>R15CA242351</funding_grant_id><funding_grant_id>R15CA249788</funding_grant_id><funding_grant_id>R15 CA242351</funding_grant_id><pubmed_authors>Ormaza D</pubmed_authors><pubmed_authors>Singh Y</pubmed_authors><pubmed_authors>Massetti A</pubmed_authors><pubmed_authors>Cudic M</pubmed_authors><pubmed_authors>Minond D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tyrosine &lt;i>O&lt;/i>-GalNAc Alters the Conformation and Proteolytic Susceptibility of APP Model Glycopeptides.</name><description>The amyloid-β precursor protein (APP) undergoes proteolytic cleavage by α-, β-, and γ-secretases, to determine its fate in Alzheimer's disease (AD) pathogenesis. Recent findings suggest a possible role of &lt;i>O&lt;/i>-glycosylation in APP's proteolytic processing. Therefore, we synthesized native and Swedish-double-mutated APP (glyco)peptides with Tyr&lt;sup>681&lt;/sup>-&lt;i>O&lt;/i>-GalNAc. We studied conformational changes and proteolytic processing using circular dichroism (CD) spectroscopy and enzyme cleavage assay, respectively. CD analysis was carried out in four solvent systems to evaluate peptide environment and &lt;i>O&lt;/i>-glycosylation induced conformational changes. The Swedish mutation and Tyr&lt;sup>681&lt;/sup>-&lt;i>O&lt;/i>-GalNAc were the key factors driving conformational changes. Furthermore, the le</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-18T15:45:04.187Z</modification><creation>2024-11-10T07:10:10.878Z</creation></dates><accession>S-EPMC8378340</accession><cross_references><pubmed>34324289</pubmed><doi>10.1021/acschemneuro.1c00387</doi></cross_references></HashMap>